Hong Farling, Ph.D.
Vice President, Clinical Operation & Data Management

Dr. Farling has served as Vice President, Clinical Operation and Data Management since October 2019. Previously, she served as Senior Director, Clinical Operation and Data Management since August of 2018.  Prior to joining Atom Bioscience,  Dr. Farling served as Director and Senior Director of Clinical Operations, Senior Clinical Trial Manager, as well as Clinical Study Monitor (Consultant) for various pharmaceutical companies such as Vaxart, Inc., Portola Pharmaceuticals, Inc., Horizon Pharma, KangLaiTe-USA, Inc., Zogenix, Inc., CV Therapeutics, Inc., Guidant Corporation, Kanglaite-USA, Inc., Galileo Laboratories, Inc., and Centaur Pharmaceuticals, Inc. Her areas of expertise include management of the clinical studies and operations services, data collection and management, review of monitoring reports, preparation of protocol/amendments, study training documents, eCRF, site training and initiation, ect. Dr. Farling has 20 years experience in Clinical Research and Operations from Phase 1 to Phase 3. Dr. Farling received her Ph.D. in Biochemistry from the State University of New York, and did her Postdoctoral Fellow at Albert Einstein College of Medicine.